Tobacco News and Research

RSS

Physicians need to know how chemical intolerance affects people: Study

Chemical intolerance contributes to the illnesses of 1 in 5 patients but the condition seldom figures in their diagnosis, according to clinical research directed by a UT Medicine San Antonio physician.

11 Jul 2012

African-American youths in public housing communities more likely to use tobacco

Today, nearly 4,000 adolescents in the United States will smoke their first cigarette, and about a fourth of those youth will become daily smokers, the U.S. Department of Health and Human Services reports. A recent study by a University of Missouri researcher found that African-American youths who live in public housing communities are 2.3 times more likely to use tobacco than other African-American youths.

11 Jul 2012

FDA approves risk evaluation and mitigation strategy for ER and LA opioids

The U.S. Food and Drug Administration today approved a risk evaluation and mitigation strategy (REMS) for extended-release (ER) and long-acting (LA) opioids, highly potent drugs approved for moderate to severe, persistent pain that requires treatment for an extended period.

10 Jul 2012

FUJIFILM receives ONC-ATCB certification for Synapse MU 3.0 EHR technology

FUJIFILM Medical Systems U.S.A. announced today that Synapse MU 3.0, is 2011/2012 compliant and was certified as a Complete EHR on June 28, 2012 by the Certification Commission for Health Information Technology, an ONC-ATCB, in accordance with the applicable eligible provider certification criteria adopted by the Secretary of Health and Human Services.

9 Jul 2012

FDA approves KRAS gene mutation test for colorectal cancer

The U.S. Food and Drug Administration today approved the first genetic test that can help some colorectal cancer (CRC) patients and their doctors determine if the drug Erbitux (cetuximab) would be an effective treatment based on the absence of a gene mutation. The therascreen KRAS RGQ PCR Kit can provide information about the KRAS gene mutation in patients whose CRC has spread to other parts of their body (metastasized).

7 Jul 2012

FDA action affects companies that manufacture and distribute unapproved oxycodone drugs

The U.S. Food and Drug Administration today issued a Federal Register notice instructing companies to stop manufacturing and distributing certain unapproved drugs that contain oxycodone. The notice is part of the FDA's Unapproved Drugs Initiative to remove unapproved new drugs from the market.

6 Jul 2012

Roche receives FDA approval for CMV viral load test

The U.S. Food and Drug Administration today approved the first DNA test to help health care professionals gauge the progress of anti-viral treatment in solid organ transplant patients undergoing cytomegalovirus (CMV) antiviral therapy.

6 Jul 2012

FDA proposes UDI regulations for most medical devices

Today, in response to requirements in legislation that passed Congress with broad bipartisan support, the U.S. Food and Drug Administration proposed that most medical devices distributed in the United States carry a unique device identifier, or UDI.

4 Jul 2012

Viewpoints: Coherent GOP plan for health care; Dems need better 'sales pitch' for health law

Hostility toward the Supreme Court has risen sharply since Chief Justice John Roberts Jr. upheld the Obama health care law. People are apparently angry that the court didn't rid them of a law they detest. But that's silly. If Americans want to replace this thing, they should do it themselves. ... Moreover, there are alternatives. Despite what you've read, there is a coherent Republican plan.

4 Jul 2012

OraSure Technologies receives FDA approval for new in-home HIV test

The U.S. Food and Drug Administration today approved the OraQuick In-Home HIV Test, the first over-the-counter, self-administered HIV test kit to detect the presence of antibodies to human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2).

4 Jul 2012

High coffee consumption appears to reduce clinical pregnancy rate by 50%

Women who drink five or more cups of coffee a day severely reduce their chance of success from IVF treatment. Indeed, Danish investigators who followed up almost 4000 IVF and ICSI patients described the adverse impact as "comparable to the detrimental effect of smoking".

4 Jul 2012

Rutgers explains significance of Supreme Court upholding the health care law

The Supreme Court upheld the core of President Obama's health care overhaul, ruling that the government can require all Americans to obtain health insurance or pay a penalty.

2 Jul 2012

Link between phthalates and early eczema uncovered

Research published in Environmental Health Perspectives suggests that prenatal exposure to butylbenzyl phthalate, a common component of vinyl flooring, may increase a child’s risk for developing early eczema.

29 Jun 2012

Astellas Pharma receives FDA approval for Myrbetriq to treat overactive bladder

The U.S. Food and Drug Administration today approved Myrbetriq (mirabegron) to treat adults with overactive bladder, a condition in which the bladder muscle cannot be controlled, squeezes too often or squeezes without warning.

29 Jun 2012

Vaccine for nicotine addiction developed

Researchers at Weill Cornell Medical College have developed and successfully tested in mice an innovative vaccine to treat nicotine addiction.

28 Jun 2012

Nanosphere receives FDA marketing approval for Verigene GP Blood Culture Nucleic Acid Test

The U.S. Food and Drug Administration today allowed marketing of the first nucleic acid test that can identify 12 different bacterial types known to cause bloodstream infections.

28 Jun 2012

Arena receives FDA approval for Belviq to treat obesity

The U.S. Food and Drug Administration today approved Belviq (lorcaserin hydrochloride), as an addition to a reduced-calorie diet and exercise, for chronic weight management.

28 Jun 2012

Gilead submits elvitegravir NDA with FDA for treatment of HIV-1 infection

Gilead Sciences, Inc. announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced adults.

28 Jun 2012

ABAM Foundation lauds findings and recommendations in Addiction Medicine

The American Board of Addiction Medicine Foundation today lauded the significant findings and recommendations in the landmark report just published by CASA Columbia, Addiction Medicine: Closing the Gap between Science and Practice.

27 Jun 2012

Exposure to BBzP during pregnancy can increase risk of eczema in children

Prenatal exposure to a ubiquitous household chemical called butylbenzyl phthalate (BBzP) can increase a child's risk for developing eczema, according to research conducted at the Columbia Center for Children's Environmental Health at the Mailman School of Public Health.

26 Jun 2012